| Patents for C07K 14 - Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof (291,526) |
|---|
| 06/17/2004 | US20040117862 Production of high levels of transgenic factor VII with engineered stability and its therapeutic uses |
| 06/17/2004 | US20040116689 can comprise DNA, RNA, PNA, or any combination or chimera thereof |
| 06/17/2004 | US20040116684 Progenitor viral nucleotide sequences for generating vaccines to prevent viral infection during xenogenic tissue and/or organ transplantation; tissue engineering |
| 06/17/2004 | US20040116683 Immunoglobulin polypeptide for prevention and/or treatment of neurological disorders and spinal injuries |
| 06/17/2004 | US20040116682 Nucleic acid molecules and other molecules associated with the carbon assimilation pathway |
| 06/17/2004 | US20040116678 Cardiac hypertrophy factor and uses therefor |
| 06/17/2004 | US20040116674 Separation of polypeptide monomers |
| 06/17/2004 | US20040116672 Human sel-10 polypeptides and polynucleotides that encode them |
| 06/17/2004 | US20040116671 Novel polypeptides and nucleic acids encoding same |
| 06/17/2004 | US20040116670 Comprises polypeptides associated with cytoplasmic network of protein fibers that mediate cell shape, structure, and movement for diagnosis, treatment and prevention of cell proliferative, viral, neurological disorders |
| 06/17/2004 | US20040116669 Prostaglandin ep1 receptor |
| 06/17/2004 | US20040116668 Zis-sr nucleic acid and amino acid sequences involved in the regulated secretory pathway and/or the regulation of the neuroendocrine phenotype (nep) |
| 06/17/2004 | US20040116667 Tyrosinase-related gene (TRP2) protein comprising human leukocyte antigen cytotoxic binding recognition points for identifying modulators for diagnosis, prevention and treatment of cancer ; immunotherapy |
| 06/17/2004 | US20040116666 Transporters and ion channels |
| 06/17/2004 | US20040116665 Vaccine composition |
| 06/17/2004 | US20040116664 Chimeric protein comprising multiprotein complex for use in development of influenza vaccine |
| 06/17/2004 | US20040116662 Comprises viral glycoprotein fusion with glutathione s-tranferase (GST) or thioredoxin for use as diagnostic tool in screening blood products for retroviral infection |
| 06/17/2004 | US20040116661 Virulence peptides from attenuated microorganism for identifying microbiocides and developing vaccines which prevent infection; veterinary medicine |
| 06/17/2004 | US20040116660 Identifying lymphadenopathy associated viral variants and using sequence homologies in envelope proteins to generate concensus sequence for use in developing vaccine aganist infection; immunotherapy; viricides |
| 06/17/2004 | US20040116659 Helicase inhibitors |
| 06/17/2004 | US20040116657 Modified peptide |
| 06/17/2004 | US20040116655 Viricides |
| 06/17/2004 | US20040116654 Isolated polypeptides; genetic engineering; quantitative analysis |
| 06/17/2004 | US20040116653 Compositions containing anti-HIV peptides and methods for use |
| 06/17/2004 | US20040116652 Method for producing and using novel human defensins as biologically active proteins for treating infections and other diseases |
| 06/17/2004 | US20040116649 Polyoxyethylene glycol; purity, storage stability |
| 06/17/2004 | US20040116372 to decrease the number of cells which may accumulate in chronic inflammatory disease by enhancing apoptosis at the site of increased cell number via gene therapy |
| 06/17/2004 | US20040116371 Methods for polysaccharide adhesion synthesis modulation |
| 06/17/2004 | US20040116369 Interferon regulatory factor-1/human estrogen receptor fusion protein and its use for treating carcinomas |
| 06/17/2004 | US20040116368 Methods for detecting and adjusting replication of hepatitis b virus and for preparing mutated virus strains with altered replication efficiency |
| 06/17/2004 | US20040116363 Useful in vaccine effective against Mannheimia haemolytica in animals |
| 06/17/2004 | US20040116346 For use in therapy of anemia, as well as in other functions associated with assays for EPO-R, studying EPO and EPO-R function, purification of EPO-R |
| 06/17/2004 | US20040116343 For inducing liver regeneration in a damaged liver tissue region of an individual |
| 06/17/2004 | US20040116342 Therapeutic use of a SMR1-peptide or a pharmaceutically active amount of SMR1-peptide, for the preparation of a therapeutic formulation for preventing or treating diseases wherein a modulation of activity of a membrane metallopeptidase is sought |
| 06/17/2004 | US20040116340 Funtional fragment of the lectine receptor |
| 06/17/2004 | US20040116338 Use of soluble forms of CD83 and nucleic acids encoding them for the treatment or prevention of diseases |
| 06/17/2004 | US20040116337 Soluble cyclic analogues of beta amyloid peptide |
| 06/17/2004 | US20040116336 Peptide derivatives |
| 06/17/2004 | US20040116335 Compositions and methods for inhibiting the proliferation and invasiveness of malignant cells comprising E-domain peptides of IGF-I |
| 06/17/2004 | US20040116333 Administering to the individual a multimeric compound that binds to at least two P-Selectin Glycoprotein Ligand 1 (PSGL-1) proteins on the surface of a T cell to induces a signal transduction pathway that results in the death of the T cell |
| 06/17/2004 | US20040116032 Electroprocessed collagen |
| 06/17/2004 | US20040115811 Method for the selection of recombination clones comprising a sequence encoding an antidote protein to a toxic molecule |
| 06/17/2004 | US20040115775 Homogeneity and secretion of recombinant proteins in mammalian systems |
| 06/17/2004 | US20040115774 Adjust pharmokinetics; ligation, binding, overlapping; nonimmunogenic; genetic engineering |
| 06/17/2004 | US20040115773 Serpin in bifidobacteria |
| 06/17/2004 | US20040115772 Methods of inhibiting Helicobacter pylori |
| 06/17/2004 | US20040115771 Genetically engineered connective tissue glycoprotein for generating biolgical scaffold for tissue repair and engineering; osteoarthritic therapy |
| 06/17/2004 | US20040115770 Preparing genetically engineered cystic fibrosis trans-membrane conductance regulator protein with enhanced activty for treatment of respiratory disorders |
| 06/17/2004 | US20040115769 Method of producing biologically active human acidic fibroblast growth factor and its use in promoting angiogenesis |
| 06/17/2004 | US20040115767 Immunogenic cell surface proteins of helicobacter pylori |
| 06/17/2004 | US20040115766 Using thermophilic microorganisms as bioreactors for generating polypeptides for use treament of skin disorders; antitumor agens; antiaging agents |
| 06/17/2004 | US20040115765 Estrogen receptor genes and utilization thereof |
| 06/17/2004 | US20040115761 Polypeptides and nucleic acids encoding same |
| 06/17/2004 | US20040115759 performed in an aqueous mixture containing less than 10% w/w aprotic polar solvent in order to reduce in vivo clearance rate |
| 06/17/2004 | US20040115747 Using expression vector coding tumor supressor protein to identify compounds which induce cell death; diagnosing xeroderma pigmentosum |
| 06/17/2004 | US20040115738 Polypeptides having a triggering nk activity and biological applications |
| 06/17/2004 | US20040115734 Binding domains between presenilins and their substrates as targets for drug screening |
| 06/17/2004 | US20040115733 Comprises tyrosine kinase receptor ligand/prohibitin protein complex for diagnosis, prevention and treatment of diabetes, cancer, osteoporosis, cardiovascular and neurodegenerative diseases |
| 06/17/2004 | US20040115715 Mismatch repair protein (MSH-5) for diagnosis, prognosis and treatment of cancer and urogenital disorders |
| 06/17/2004 | US20040115714 Comprises nucleotide coding sequences associated with breast cancer cell-2 (BRCC-2) genes and proteins for use in the identification of modulators for prevention and treatment of tumors |
| 06/17/2004 | US20040115702 Type 2 diabetes susceptibility genes |
| 06/17/2004 | US20040115700 Comprises nucleotide sequences coding transcriptional splice variants of hippocampal and mammary gland negative regulatory protein for use in diagnosis and treatment of alzheimer's disease |
| 06/17/2004 | US20040115698 Interleukin 17 receptor-like protein |
| 06/17/2004 | US20040115690 Method of detecting inflammatory lung disorders |
| 06/17/2004 | US20040115687 Comprise matrix polypeptide for diagnosis, treatment, and prevention of immunological, nervous system, developmental, connective tissue and cell proliferative disorders |
| 06/17/2004 | US20040115682 Comprises nucleotide sequences coding membrane protein associated with modifying low density lipoproteins for diagnosis and treatment of cardiovascular disorders |
| 06/17/2004 | US20040115678 Dna markers for meat tenderness |
| 06/17/2004 | US20040115676 G-protein coupled receptors |
| 06/17/2004 | US20040115675 Regulation of human transient receptor potential channel |
| 06/17/2004 | US20040115668 Human hyperpolarization-activated cyclic nucleotide-gated cation channel hcn3 |
| 06/17/2004 | US20040115667 Dna-sequences, which code for an apoptosis signal transduction protein |
| 06/17/2004 | US20040115661 Shuttle vector for use as stable gene transfer tool in genetic engineering |
| 06/17/2004 | US20040115660 Method of diagnosising abnormalities by screening for tyrosine kinase like molecules or their signalling mediators |
| 06/17/2004 | US20040115659 Methods of isolating genes encoding proteins of specific function and of screening for pharmaceutically active agents |
| 06/17/2004 | US20040115656 Androgen receptor down-regulatory-associated proteins(ARDAPs) for use in reduction of transactivation activity of androgen receptors and treatment of tumors; gene expression inhibition and anticarcinogenic agents |
| 06/17/2004 | US20040115630 Comprises oligomeric peptide nucleic acid for identifying cytosine methylation state of genomic DNA and classifying, diagnosing and treating of brain tumors |
| 06/17/2004 | US20040115629 Molecules for diagnostics and therapeutics |
| 06/17/2004 | US20040115628 Atrsp gene promoters |
| 06/17/2004 | US20040115626 Comprises nucleotide sequences coding peroxisome proliferator activator receptor gamma coactivator-1 (PGC-1) regulatory sequences for use as tool in identifying modulators of mitochondrial activity and treatments for odesity and diabetes |
| 06/17/2004 | US20040115622 Mixture of peptides originating from a Nef protein and applications thereof |
| 06/17/2004 | US20040115621 Ancestral viruses and vaccines |
| 06/17/2004 | US20040115617 Diagnosing viral food poisioning using genetically engineered viral RNA sequences |
| 06/17/2004 | US20040115615 Comprises amino acid sequences capable of inducing lymphadenopathy immune response without antagonizing cytotoxic lymphocytes; viricides and prevention of viral diseases |
| 06/17/2004 | US20040115219 Pharmaceutical composition for prophylaxis and therapy of papillomavirus-derived diseases comprising papillomavirus antigen protein and CpG-oligodeoxynucleotide |
| 06/17/2004 | US20040115218 Ubiquitin fusion-based vaccine system |
| 06/17/2004 | US20040115217 Bystander suppression of autoimmune diseases |
| 06/17/2004 | US20040115216 Reagents and methods for engaging unique clonotypic lymphocyte receptors |
| 06/17/2004 | US20040115215 Recombinant botulinum toxins with a soluble C-terminal portion, an N-terminal portion and a light chain |
| 06/17/2004 | US20040115212 Attenuated microorganism strains and their uses |
| 06/17/2004 | US20040115211 fusions between ESAT-6 and MPT59 are superior immunogens |
| 06/17/2004 | US20040115202 monospecific antibody which specifically binds an epitope of a mammalian DPPIV (dipeptidyl peptidase IV, also known as CD26). |
| 06/17/2004 | US20040115200 administering to cerebrospinal fluid anti-TNF antibodies, fragments and regions thereof that are specific for human tumor necrosis factor- alpha |
| 06/17/2004 | US20040115199 Method for down-regulating osteoprotegerin ligand activity |
| 06/17/2004 | US20040115184 Methods and compositions for modifying apolipoprotein b mrna editing |
| 06/17/2004 | US20040115180 Carrier chimeric proteins targeted carrier chimeric proteins and preparation thereof |
| 06/17/2004 | US20040115169 Methods of protein purification and recovery |
| 06/17/2004 | US20040115168 cell-free, in vitro method of ataching a specific glycan structure; treating multiple sclerosis |
| 06/17/2004 | US20040115166 Method of treatment and prophylaxis |
| 06/17/2004 | US20040115129 Nucleic acid sequence 1 or 3; amino acid sequence 2 or 4 |
| 06/17/2004 | US20040115128 Targeting endothelium for tissue-specific delivery of agents |